Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Godfrey

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
California Medicine|October 1, 1971
Mithramycin for hypercalcemia of malignant diseaseT E Godfrey
Seminars in Oncology|June 1, 1988
Mitomycin C in advanced breast cancer: an updateT E Godfrey
Minerva Chirurgica|February 20, 2003
The role of tumor suppressor genes in esophageal cancerS Raja, T E Godfrey, J D Luketich
Medical and Pediatric Oncology|January 1, 1976
Mitomycin C in large infrequent doses in breast cancerG R Wise, I N Kuhn, T E Godfrey
Cancer Genetics and Cytogenetics|October 6, 1997
Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinomaT E Godfrey, M L Cher, V Chhabra, et al.
International Journal of Radiation Biology|June 1, 1995
Characterization of a mammalian cell line that exhibits spontaneous and ultraviolet light-induced hypermutability while retaining resistance to cell killing by ultraviolet lightT E Godfrey, M Ikebuchi, R J Reynolds, et al.
Cancer Treatment Reports|January 1, 1982
Elevation of plasma antidiuretic hormones (ADH) associated with chemotherapy-induced emesis in manR D Fisher, R E Rentschler, J C Nelson, et al.
Gut|December 16, 2005
A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetranceA Khalid, S Finkelstein, B Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patientsT E Godfrey, S Raja, S D Finkelstein, et al.
American Journal of Human Genetics|January 13, 2000
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndromeF Tassone, R J Hagerman, A K Taylor, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
California Medicine|October 1, 1971
Mithramycin for hypercalcemia of malignant diseaseT E Godfrey
Seminars in Oncology|June 1, 1988
Mitomycin C in advanced breast cancer: an updateT E Godfrey
Minerva Chirurgica|February 20, 2003
The role of tumor suppressor genes in esophageal cancerS Raja, T E Godfrey, J D Luketich
Medical and Pediatric Oncology|January 1, 1976
Mitomycin C in large infrequent doses in breast cancerG R Wise, I N Kuhn, T E Godfrey
Cancer Genetics and Cytogenetics|October 6, 1997
Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinomaT E Godfrey, M L Cher, V Chhabra, et al.
International Journal of Radiation Biology|June 1, 1995
Characterization of a mammalian cell line that exhibits spontaneous and ultraviolet light-induced hypermutability while retaining resistance to cell killing by ultraviolet lightT E Godfrey, M Ikebuchi, R J Reynolds, et al.
Cancer Treatment Reports|January 1, 1982
Elevation of plasma antidiuretic hormones (ADH) associated with chemotherapy-induced emesis in manR D Fisher, R E Rentschler, J C Nelson, et al.
Gut|December 16, 2005
A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetranceA Khalid, S Finkelstein, B Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patientsT E Godfrey, S Raja, S D Finkelstein, et al.
American Journal of Human Genetics|January 13, 2000
Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndromeF Tassone, R J Hagerman, A K Taylor, et al.
Pageof 2